🇺🇸 FDA
Patent

US 10857106

Methods and products for treating and/or delaying onset of dysplastic lesions

granted A61KA61K2039/54A61K2039/542

Quick answer

US patent 10857106 (Methods and products for treating and/or delaying onset of dysplastic lesions) held by The Regents of the University of Colorado, a Body Corporate expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of Colorado, a Body Corporate
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/54, A61K2039/542, A61K2039/543, A61K2039/544